Name: UMIN ID:
Unique ID issued by UMIN | UMIN000017014 |
---|---|
Receipt number | R000019628 |
Scientific Title | A Phase 2b, Multi-center, Double-blind, Placebo-controlled, Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets on HbA1c in Subjects with Type 2 Diabetes Mellitus |
Date of disclosure of the study information | 2015/04/01 |
Last modified on | 2016/10/11 15:30:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/04/01 21:30:00 | ||
2 | Update | 2015/05/19 10:43:59 | Recruitment status Anticipated trial start date |
|
3 | Update | 2015/05/19 10:46:08 | Institute Institute Organization Organization |
|
4 | Update | 2016/05/13 15:34:49 | Address Address TEL Address Address TEL Name of primary person or sponsor Organization |
|
5 | Update | 2016/10/11 15:30:18 | Recruitment status |